Thursday, November 03, 2011 5:48:37 PM
Someone said $15 after approval.
Someone said maybe $20.
PCRX is at $7.00 now.
It's no wonder people have a dime view of the markets.
Cheers!
Recent PCRX News
- Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the Knee • GlobeNewswire Inc. • 03/13/2024 11:00:00 AM
- Pacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare Conference • GlobeNewswire Inc. • 03/06/2024 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 08:33:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 01:03:32 PM
- Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results • GlobeNewswire Inc. • 02/29/2024 01:00:00 PM
- Pacira to Report 2023 Financial Results on Thursday February 29, 2024 • GlobeNewswire Inc. • 02/22/2024 01:00:00 PM
- Pacira Announces Publication of Pivotal Study of EXPAREL as a Sciatic Nerve Block in the Popliteal Fossa for Patients After Bunionectomy • GlobeNewswire Inc. • 02/15/2024 01:36:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:59:39 PM
- Pacira BioSciences Awarded Brand Pharmaceuticals Agreement With Premier, Inc. • GlobeNewswire Inc. • 02/07/2024 01:00:00 PM
- G.O.A.T. Bowl I Registration Open to 4 Additional Pickleball Teams • PR Newswire (US) • 02/01/2024 03:45:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 10:25:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 10:24:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 10:21:34 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 10:18:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 10:02:42 PM
- Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues • GlobeNewswire Inc. • 01/04/2024 10:00:41 PM
- Pacira BioSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/03/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 12:33:59 PM
- Pacira Appoints Frank D. Lee as Chief Executive Officer • GlobeNewswire Inc. • 12/21/2023 12:30:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 12:44:29 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/13/2023 02:41:16 PM
- Pacira Announces FDA Approval of Expanded EXPAREL Label to Include Two Additional Nerve Block Indications • GlobeNewswire Inc. • 11/10/2023 12:30:00 PM
- Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in November • GlobeNewswire Inc. • 11/07/2023 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/02/2023 06:59:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 12:01:26 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM